FCAG
DGX icon

First Capital Advisors Group’s Quest Diagnostics DGX Stock Holding History

First Capital Advisors Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$85.6K Buy
+609
New +$84K 0.04% 233
2018
Q2 		– Sell
-131
Closed -$13K – 312
2018
Q1 		$13K Buy
+131
New +$13.4K 0.01% 502

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

First Capital Advisors Group's DGX Position: Q2 2023 in Review

First Capital Advisors Group opened a new position in Quest Diagnostics (DGX) in Q2 2023: 609 shares worth $85.6K. The stake represents 0.04% of the portfolio and ranks #233 among its holdings. This is a return to the name: First Capital Advisors Group previously reported a position in DGX as recently as Q1 2018.

First Capital Advisors Group first reported a position in DGX in Q1 2018 and has held it in 2 quarters since. 819 funds tracked by Wall St. Rank hold DGX as of Q2 2023.

  • First Capital Advisors Group held 609 shares of Quest Diagnostics worth $85.6K as of Q2 2023.
  • Quest Diagnostics was a new First Capital Advisors Group position in Q2 2023.
  • Quest Diagnostics made up 0.04% of First Capital Advisors Group's portfolio in Q2 2023, its #233 holding.
  • First Capital Advisors Group first reported a position in Quest Diagnostics in Q1 2018 and has held it in 2 quarters since.
  • 819 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2023.

Based on First Capital Advisors Group's 13F filing for Q2 2023, filed 15 Aug 2023.